Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23174368 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed High-Density Lipoprotein (HDL) Modulation and Endothelial Function
Condition: Atherosclerosis
Intervention: Drug: atorvastatin (or other tolerated statin + Niaspan/placebo)

Indicates status has not been verified in more than two years